title: Hot topics on diabetes in China.
abstract: China is the country with the largest burden of diabetes worldwide. Action is now taking place at different levels by the Chinese Diabetes Society, which has a major role in coordinating multi-level activities across the country. These include, among others, the implementation of local guidelines for therapy, campaigns for education, trials for type 2 diabetes prevention and the establishment of extensive international collaborations in basic as well as clinical research. In this Special Issue, we briefly report on such initiatives, among which is a scientifically sound approach to exploring Chinese traditional medicine as a therapeutic option for diabetes treatment.
authors.affiliation: Chinese Diabetes Society, Beijing, China.|Department of Endocrinology and Metabolism, The Third Affiliated Hospital Sun Yat-sen University, Guangzhou, China.
authors.forename: Jianping
authors.initials: J
authors.lastname: Weng
authors.affiliation: Unit of Endocrinology and Diabetes, Department of Medicine, Universita' Campus Bio-Medico di Roma, Italy.|Centre of Immunobiology, Barts and the London School of Medicine, Queen Mary, University of London, London, UK.
authors.forename: Paolo
authors.initials: P
authors.lastname: Pozzilli
mesh_terms: D035843:Biomedical Research; D002681:China; D003924:Diabetes Mellitus, Type 2; D006801:Humans